taxonomy (2)
protein (7)
source (3)
structure (39)
composition (28)
disease (4)
reference (7)
site (7)
peptide (0)
- Intercellular adhesion molecule-3 (CD50) / Homo sapiens P32942
- Leukosialin (cd43) / Homo sapiens P16150
- Receptor-type tyrosine-protein phosphatase C / Homo sapiens P08575
- Uncharacterized protein / Mus musculus
- Uncharacterized protein / Mus musculus
- Uncharacterized protein / Mus musculus
- Uncharacterized protein / Mus musculus
Protein
- BW5147 (CVCL_3896) T-Lymphocyte (CL_0000084)
- CCRF-CEM (CVCL_0207) T-Lymphocyte (CL_0000084)
- T-Lymphocyte (CL_0000084)
Source
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Gal(a1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-3)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x Gal(a1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Gal(b1-3)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-3)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Gal(b1-3)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Gal(b1-4)GlcNAc(b1-3) + Gal(b1-3)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x Gal(b1-4)GlcNAc(b1-3) + Gal(b1-3)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 3 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Gal(b1-4)GlcNAc(b1-3) + Gal(b1-3)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 3 x Gal(b1-4)GlcNAc(b1-3) + Gal(b1-3)GlcNAc(b1-3)"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-2)Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Man(a1-2)"
- O-Linked / Core 0 / GalNAc
- O-Linked / Core 1 / Gal(b1-3)GalNAc
- O-Linked / Core 1 / Gal(b1-3)GalNAc+"+ NeuAc"
- O-Linked / Core 1 / NeuAc(a2-3)Gal(b1-3)GalNAc
- O-Linked / Core 1 / NeuAc(a2-3)Gal(b1-3)[NeuAc(a2-6)]GalNAc
- O-Linked / Core 2 / Gal(b1-4)GlcNAc(b1-6)[Gal(b1-3)]GalNAc+"+ NeuAc(a2-3)"
- O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
- O-Linked / O-GlcNAc / GlcNAc(b
Reported structure
- HexNAc:1 (avg mass : 221.2103 )
- Hex:1 HexNAc:1 (avg mass : 383.3527 )
- Hex:1 HexNAc:1 NeuAc:1 (avg mass : 674.6106 )
- Hex:1 HexNAc:1 NeuAc:2 (avg mass : 965.8685 )
- Hex:2 HexNAc:2 NeuAc:1 (avg mass : 1039.948 )
- Hex:2 HexNAc:2 NeuAc:2 (avg mass : 1331.2059 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:4 (avg mass : 1803.6497 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:7 HexNAc:4 (avg mass : 1965.7921 )
- Hex:7 HexNAc:4 dHex:1 (avg mass : 2111.9351 )
- Hex:7 HexNAc:5 dHex:1 (avg mass : 2315.1301 )
- Hex:7 HexNAc:6 (avg mass : 2372.1821 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:8 HexNAc:5 dHex:1 (avg mass : 2477.2725 )
- Hex:8 HexNAc:7 (avg mass : 2737.5195 )
- Hex:8 HexNAc:7 dHex:1 (avg mass : 2883.6625 )
- Hex:9 HexNAc:8 (avg mass : 3102.8569 )
- Hex:9 HexNAc:8 dHex:1 (avg mass : 3248.9999 )
- Hex:10 HexNAc:9 (avg mass : 3468.1943 )
- Hex:10 HexNAc:9 dHex:1 (avg mass : 3614.3373 )
- Hex:11 HexNAc:10 (avg mass : 3833.5317 )
- Hex:11 HexNAc:10 dHex:1 (avg mass : 3979.6747 )
Composition
- Leukemia, Acute lymphoblastic (DOID:9952)
- Leukemia, Acute lymphoblastic and HIV-1
- Lymphoma, Thymic (DOID:10146)
- Wiskott-Aldrich Syndrome (DOID:9169)
Disease
- Structural study of N-linked oligosaccharides of human intercellular adhesion molecule-3 (CD50). (2001 - Funatsu O, Sato T, Kotovuori P, Gahmberg CG, Ikekita M, Furukawa K) / Status : Reviewed
- Altered sialylation of CD45 in HIV-1-infected T lymphocytes. (1994 - Lefebvre J, Giordanengo V, Doglio A, Cagnon L, Breittmayer J, Peyron J, Lesimple J) / Status : Reviewed
- Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. (1991 - Kearse KP, Hart GW) / Status : Reviewed
- Cell type and maturation stage-dependent polymorphism of N-linked oligosaccharides on murine lymphocytes and lymphoma cells. (1991 - Yoshida T, Takahashi N, Nakashima I) / Status : Reviewed
- Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome. (1991 - Piller F, Le Deist F, Weinberg K, Parkman R, Fukuda M) / Status : Reviewed
- Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. (1988 - Piller F, Piller V, Fox R, Fukuda M) / Status : Reviewed
- Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. (1984 - Torres C, Hart G) / Status : Reviewed
Reference
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
Leukosialin (cd43) / Homo sapiens
- Undefined site
-
Receptor-type tyrosine-protein phosphatase C / Homo sapiens
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
Reported glycosite
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1641.5073)
- Lymphoma, Thymic (DOID:10146)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Lymphoma, Thymic (DOID:10146)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1803.6497)
- Lymphoma, Thymic (DOID:10146)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Lymphoma, Thymic (DOID:10146)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1965.7921)
- Lymphoma, Thymic (DOID:10146)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2006.8447)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2006.8447)
- T-Lymphocyte (CL_0000084)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2111.9351)
- Lymphoma, Thymic (DOID:10146)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Lymphoma, Thymic (DOID:10146)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2152.9877)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2152.9877)
- Lymphoma, Thymic (DOID:10146)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2315.1301)
- Lymphoma, Thymic (DOID:10146)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2372.1821)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2372.1821)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2477.2725)
- Lymphoma, Thymic (DOID:10146)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2518.3251)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2518.3251)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2737.5195)
- Lymphoma, Thymic (DOID:10146)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2737.5195)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2737.5195)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2883.6625)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2883.6625)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3102.8569)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3248.9999)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3468.1943)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3614.3373)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3833.5317)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3979.6747)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1235.1173)
- Lymphoma, Thymic (DOID:10146)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1397.2597)
- Lymphoma, Thymic (DOID:10146)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
- N-Linked / High-Mannose
(avg mass : 1397.2597)
- T-Lymphocyte (CL_0000084)
-
Intercellular adhesion molecule-3 (CD50) / Homo sapiens
- Undefined site
-
- O-Linked / Core 0
(avg mass : 221.2103)
-
Receptor-type tyrosine-protein phosphatase C / Homo sapiens
- Undefined site
-
- O-Linked / Core 1
(avg mass : 383.3527)
-
Receptor-type tyrosine-protein phosphatase C / Homo sapiens
- Undefined site
-
- O-Linked / Core 1
(avg mass : 674.6106)
- T-Lymphocyte (CL_0000084)
- Wiskott-Aldrich Syndrome (DOID:9169)
-
Leukosialin (cd43) / Homo sapiens
- Undefined site
-
- O-Linked / Core 1
(avg mass : 674.6106)
-
Receptor-type tyrosine-protein phosphatase C / Homo sapiens
- Undefined site
-
- O-Linked / Core 1
(avg mass : 965.8685)
- T-Lymphocyte (CL_0000084)
- Wiskott-Aldrich Syndrome (DOID:9169)
- Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome. (1991 - Piller F, Le Deist F, Weinberg K, Parkman R, Fukuda M) / Status : Reviewed
- Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. (1988 - Piller F, Piller V, Fox R, Fukuda M) / Status : Reviewed
-
Leukosialin (cd43) / Homo sapiens
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1039.948)
- T-Lymphocyte (CL_0000084)
- Wiskott-Aldrich Syndrome (DOID:9169)
-
Leukosialin (cd43) / Homo sapiens
- Undefined site
-
- O-Linked / Core 2
(avg mass : 1331.2059)
- T-Lymphocyte (CL_0000084)
- Wiskott-Aldrich Syndrome (DOID:9169)
- Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome. (1991 - Piller F, Le Deist F, Weinberg K, Parkman R, Fukuda M) / Status : Reviewed
- Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. (1988 - Piller F, Piller V, Fox R, Fukuda M) / Status : Reviewed
-
Leukosialin (cd43) / Homo sapiens
- Undefined site
-
- O-Linked / O-GlcNAc
(avg mass : 221.2103)
- T-Lymphocyte (CL_0000084)
- Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. (1991 - Kearse KP, Hart GW) / Status : Reviewed
- Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. (1984 - Torres C, Hart G) / Status : Reviewed
-
Uncharacterized protein / Mus musculus
- Undefined site
Source
Reference
Reported glycosite
- O-Linked / O-GlcNAc
(avg mass : 221.2103)
Source
Disease
Reference
Reported glycosite
- O-Linked / Core 2
(avg mass : 1331.2059)
Source
Disease
Reported glycosite
- O-Linked / Core 2
(avg mass : 1039.948)
Source
Disease
Reference
Reported glycosite
- O-Linked / Core 1
(avg mass : 965.8685)
Reported glycosite
- O-Linked / Core 1
(avg mass : 674.6106)
Source
Disease
Reported glycosite
- O-Linked / Core 1
(avg mass : 674.6106)
Reported glycosite
- O-Linked / Core 1
(avg mass : 383.3527)
Reported glycosite
- O-Linked / Core 0
(avg mass : 221.2103)
Source
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1397.2597)
Disease
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1397.2597)
Disease
Reported glycosite
- N-Linked / High-Mannose
(avg mass : 1235.1173)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3979.6747)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3833.5317)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3614.3373)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3468.1943)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3248.9999)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3102.8569)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2883.6625)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2883.6625)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2737.5195)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2737.5195)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2737.5195)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2518.3251)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2518.3251)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2477.2725)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2372.1821)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2372.1821)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2315.1301)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2152.9877)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2111.9351)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2006.8447)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2006.8447)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1965.7921)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1803.6497)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 1641.5073)